Join Wisconsin’s Thriving Biohealth Industry

The Morgridge Institute for Research is a private, nonprofit research institute dedicated to improving human health through interdisciplinary biomedical research, in partnership with the University of Wisconsin-Madison.

Nelambos LLC is a biotech start up with a focus on developing a simple, diagnostic assay for the early detection of urinary tract infections (UTIs). Urinary tract infections are one of the most common bacterial infections and approximately 150 million individuals are affected each year worldwide with the prevalence being higher in women. UTIs are also a major concern in the elderly and can lead to UTI-associated sepsis requiring hospitalization. By detecting the infection earlier on and seeking medical attention more serious consequences such as sepsis and hospitalization can be reduced.

We are motivated by people living with diseases and conditions that are without viable treatment options. We identify the greatest needs and work relentlessly to bring hope to those who need it most.

For 50 years, New England Biolabs has led the industry in the discovery and production of molecular biology reagents. In addition to products for genomic research, NEB continues to expand its product offerings into areas related to PCR, gene expression, sample prep for next gen sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis.

Nexus Pharmaceuticals is a research & development driven specialty drug developer and manufacturer with a focus on critical-need injectable medications.

We are a recognized, emerging global leader with a proven track record and strong vision for the future of radiopharmaceuticals. Our innovation-driven technology is transforming the landscape for medical radioisotope production and distribution around the world.

Novartis provides healthcare solutions that improve and extend people's lives. We use science-based innovation to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. Novartis is focused on industry-leading divisions with innovation power and global scale: pharmaceuticals, eye care and generic medicines

Object Pharma is currently manufacturing and selling all seven serotypes of botulinum toxin for use by accredited researchers on a worldwide basis. Metabiologics manufactures toxin products to the highest industry standard for purity and specific activity. Customized product specifications and order quantities are available upon request. Antibodies to botulinum toxins are now available.

Contract Manufacturing, Pharmaceutical Fill/Finish

PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory, and lifecycle management services. Our customers include pharmaceutical, biotechnology, medical device, and academic and government organizations. With offices in 46 countries and approximately 24,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.

At PROMISS Diagnostics, we aim to help clinicians detect ovarian cancer early, while lowering costs and improving patient outcomes. That's why we developed PROMISS -- an innovative, non-invasive ovarian cancer diagnostic test that brings certainty for patients and clinicians.

Pfizer is the world's largest research-based biomedical and pharmaceutical company. We have a leading portfolio of medicines that prevent, treat and cure diseases across a broad range of therapeutic areas, and an industry-leading pipeline of promising new products in areas such as oncology, cardiovascular disease and diabetes.

Plumb Pharmaceuticals has developed a drug delivery platform for super-extended-release medications based on proprietary liposome preparation and loading technology. Our patented Advanced Quantload (AQL) system extends drug release from 72 hours to more than 3 months compared to current delivery systems. Super-extended release technology will significantly increase patient compliance and reduce healthcare costs making it attractive to many pharmaceutical partners.

PSI manufactures sensitive medical and laboratory solutions and products including organ transplant solutions and cell processing solutions. We have small batch capabilities and welcome research and clinical studies. FDA registered and ISO certified.

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company's portfolio of over 4,000 products support a range of life science work across areas such as cell biology; DNA, RNA and protein analysis; drug development; human identification and molecular diagnostics. For almost 45 years these tools and technologies have grown in their application and are used today by scientists and technicians in labs for academic and government research, forensics, pharmaceuticals, clinical diagnostics and agricultural and environmental testing. Promega is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. For more information, visit www.promega.com.

Using streamlined and scalable recombinant production methods developed at the Medical College of Wisconsin, we are committed to supplying the highest quality recombinant proteins in terms of chemical purity, structural homogeneity and functional potency. In addition, we offer custom chemokine production services, including metabolic labeling with stable isotopes for use in NMR or mass spectrometric applications.

Quincy Bioscience is a biotechnology company based in Madison, Wisconsin, that focuses on the discovery, development, and commercialization of novel technologies to support cognitive function and other normal health challenges associated with aging. Quincy Bioscience is set apart by its cutting-edge applications of apoaequorin which is breaking new ground with apoaequorin, originally discovered in jellyfish, now patented by Quincy Bioscience for use in a variety of products to support cognitive function. Apoaequorin is manufactured in a cGMP compliant facility.

RPRD Diagnostics, based in Milwaukee, Wisconsin, was founded in 2016. Our mission is to become the leader in comprehensive pharmacogenetic testing, with the goal of bringing cost-effective precision medicine to the masses. To achieve this we have built a state-of-the-art facility with leading edge infrastructure, complemented by a world-class team of clinicians and diagnostics experts. We aim to enable hospitals, clinicians, and their patients to better understand and manage their treatment choices on the basis of each individual's unique genetic profile.

We design, manufacture, and sell bioprocessing Single-Use components and assemblies for the biopharmaceutical industry.

Retham Technologies seeks to revolutionize the diagnosis and management of Heparin induced thrombocytopenia (HIT).